http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7550752-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_108e557a1e079b5781d8f98ae0e9cc88
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1087
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b034a69b83250034dcd8177ed482f3be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f3d54d3b0afe8c1bfec63511f730ce9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d5f0fa5688bcba9b4fed9c2a1be8ae
publicationDate 2009-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7550752-B2
titleOfInvention Hadron treatment planning with adequate biological weighting
abstract Treatment planning methods are provided that determine the variability of relative biological effectiveness (RBE) along a beam line and calculate, among other things, what intensity of hadron beam such as a proton or a carbon ion beam should be applied to achieve a desired biological dose at treatment site of a patient afflicted with a medical condition. Typically, three or four RBE values at three or four corresponding spacially-dispersed intervals along the beam line are calculated. In one embodiment, two RBE values for the spread-out Bragg peak (SOBP) region of the treatment site; one for the proximal section and one for the declining distal section is calculated. A third and different RBE value may be determined for the distal edge region of the SOBP. A fourth value may also be calculated for a pre-SOBP region.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10307618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011319741-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10974076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9855445-B2
priorityDate 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008164416-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7268358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006145088-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54078102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611546

Total number of triples: 33.